REVB (Revelation Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena

REVBRevelation Biosciences, Inc.

Mkt Cap$2M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$9M

EPS (TTM)-$12.54

Free Cash Flow (TTM)-$8.3B

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$6K	-$2M
Q2 23	$0	-$6K	-$2M
Q3 23	$0	-$6K	-$3M
Q4 23	$38K	$19K	-$2M
Q1 24	$0	-$6K	-$2M
Q2 24	$0	-$7K	-$3M
Q3 24	$0	-$7K	-$2M
Q4 24	$27K	$13K	-$2M
Q1 25	$0	-$7K	-$2M
Q2 25	$0	-$7K	-$2M
Q3 25	$0	-$7K	-$2M
Q4 25	$0	-$6K	-$3M

Valuation

Quarter	P/S	P/E
Q1 23	—	1.0x
Q2 23	—	0.8x
Q3 23	—	2.2x
Q4 23	51.2x	—
Q1 24	51.2x	—
Q2 24	51.2x	—
Q3 24	51.2x	—
Q4 24	71.4x	—
Q1 25	71.4x	—
Q2 25	71.4x	—
Q3 25	71.4x	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$2M	-$2M
Q2 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$2M	-$2M
Q1 24	-$3M	-$3M
Q2 24	-$2M	-$2M
Q3 24	-$9M	-$9M
Q4 24	-$4M	-$4M
Q1 25	-$3M	-$3M
Q2 25	-$2M	-$2M
Q3 25	-$2M	-$2M
Q4 25	-$8.3B	-$8.3B

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$19K
Q2 24	$0
Q3 24	$18K
Q4 24	$18K
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-75.4%
Q2 23	—	+3.9%
Q3 23	—	+131.6%
Q4 23	—	+94.0%
Q1 24	—	+17.4%
Q2 24	—	+30.5%
Q3 24	—	-35.3%
Q4 24	-28.2%	-24.7%
Q1 25	—	+10.1%
Q2 25	—	-2.4%
Q3 25	—	+8.1%
Q4 25	-100.0%	+44.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$32K	—
Q2 23	$59K	—
Q3 23	$32K	—
Q4 23	$32K	85.4%
Q1 24	$32K	—
Q2 24	$32K	—
Q3 24	$32K	—
Q4 24	$73K	269.1%
Q1 25	$223K	—
Q2 25	$873	—
Q3 25	$874	—
Q4 25	$595M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$525K	$1M
Q2 23	$909K	$1M
Q3 23	$2M	$1M
Q4 23	$1M	$1M
Q1 24	$718K	$1M
Q2 24	$1M	$1M
Q3 24	$831K	$966K
Q4 24	$606K	$1M
Q1 25	$859K	$1M
Q2 25	$1M	$1M
Q3 25	$923K	$1M
Q4 25	$4.1B	$5.0B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$18M	$0	$18M
Q2 23	$16M	$0	$16M
Q3 23	$14M	$0	$14M
Q4 23	$12M	$0	$12M
Q1 24	$15M	$0	$15M
Q2 24	$12M	$0	$12M
Q3 24	$7M	$0	$7M
Q4 24	$6M	$0	$6M
Q1 25	$4M	$0	$4M
Q2 25	$5M	$0	$5M
Q3 25	$13M	$0	$13M
Q4 25	$10.7B	$0	$10.7B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	7K	+359.4%
Q2 23	12K	+85.3%
Q3 23	13K	+8.3%
Q4 23	17K	+26.0%
Q1 24	68K	+312.0%
Q2 24	102K	+50.0%
Q3 24	167K	+63.9%
Q4 24	347K	+106.9%
Q1 25	971K	+180.3%
Q2 25	803K	-17.4%
Q3 25	3M	+229.5%
Q4 25	6M	+134.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	$0	2
FY 21	$0	14
FY 22	$0	18
FY 23	$0	10
FY 24	$0	9
FY 25	$0	9

REVB (Revelation Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena